← All Sponsors
SPONSOR

LimmaTech Biologics AG

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Shigellosis
NCT06615375 Phase 2
Recruiting

A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine

Shigellosis
United States View Trial →